NeuroDex CEO Dr. Erez Eitan to Present Advances in Blood-Based Biomarkers at LSU Health’s 6th Arthur L. Haas Endowed Lecture

NeuroDex CEO and Chief Scientific Officer, Dr. Erez Eitan, has been invited to deliver the 6th Arthur L. Haas Endowed Lecture at LSU Health New Orleans on November 11, 2026.

The lecture, titled "Developing Neuron-Derived Extracellular Vesicles as a Versatile Biomarker Platform: Lessons from α-Synuclein and TDP-43," will highlight NeuroDex's progress in developing innovative approaches to studying neurodegenerative diseases through blood-based biomarkers.

Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

NeuroDex is pioneering the use of neuron-derived extracellular vesicles (NDEVs) to access molecular information associated with the brain through minimally invasive blood sampling.

Using its proprietary ExoSORT™ platform, NeuroDex isolates and analyzes NDEVs from blood, enabling the measurement of brain-associated proteins and other molecular biomarkers.

During the lecture, Dr. Eitan will present findings from NeuroDex's research in Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease, focusing on α-synuclein and TDP-43, two proteins closely linked to neurodegenerative pathology.

The presentation will explore how NDEV-based biomarkers could provide new tools for monitoring disease progression, evaluating therapeutic responses, and supporting clinical trials for neurodegenerative disorders.

Honoring the Legacy of Dr. Arthur Haas

Established in 2014, the Arthur L. Haas Endowed Lectureship recognizes distinguished scientists whose contributions reflect excellence in research, education, and scientific leadership.

Dr. Arthur Haas made pioneering contributions to the understanding of ubiquitin-mediated protein regulation, helping establish fundamental concepts in cellular biology with broad implications for human health and disease.

Dr. Eitan's invitation highlights the growing scientific interest in extracellular vesicle research and its potential to advance translational neuroscience and biomarker development.

Lecture Details

Event: 6th Arthur L. Haas Endowed Lectureship
Speaker: Erez Eitan, PhD, CEO and CSO, NeuroDex, Inc.
Date: November 11, 2026
Time: 1:00-2:00 PM
Location: LSU Health New Orleans, AHN 228

Connect With NeuroDex

Researchers, clinicians, and biotechnology and pharmaceutical teams interested in neuron-derived extracellular vesicles, blood-based biomarkers, or their applications in neurodegenerative disease research and therapeutic development are invited to connect with the NeuroDex team to learn more about our technology, research, and potential collaboration opportunities.

To start a conversation, contact us at neurodex.co .